United States · FDA National Drug Code directory
ATMEKSI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69528-701_4ce9560d-185c-1e28-e063-6294a90af77f
- Product NDC
- 69528-701
- Form
- SUSPENSION
- Composition / generic term
- methocarbamol
- Labeler
- Rosemont Pharmaceuticals LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20251222
- Source listing expiry
- 20271231
Source-listed ingredients
- METHOCARBAMOL — 750 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 150 mL in 1 BOTTLE (69528-701-05) · 69528-701-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →